We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · August 04, 2021

Immunosuppressants and COVID-19 in Elderly IBD Patients

Aging Clinical and Experimental Research


Additional Info

Disclosure statements are available on the authors' profiles:

Aging Clinical and Experimental Research
Impact of Immunosuppressants on SARS-Cov-2 Infection in Elderly Patients With Inflammatory Bowel Disease
Aging Clin Exp Res 2021 Aug 01;33(8)2355-2359, M Calafat, C González-Muñoza, M Fortuny, C Roig, A Calm, A Mombiela, F Cañete, F Bertoletti, L González-González, M Teller-Martín, J Gordillo, M Mañosa, E Garcia-Planella, E Domènech

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading